ARCHIVES

DCPC Board Okays Reissuance Of RFA for Chemoprevention Clinical Trials

This article is from The Cancer Letter archive.

Vol. 14 No. 21 | May 20, 1988

Download PDF Visit The Full Archive

Related Articles

FDA Approves Velcade For Treatment Of Refractory Multiple Myeloma

May 30, 2003

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

December 5, 1986

Clinical Societies, Patient Groups Need New Alliance, Glick Proposes to ASCO

May 24, 1996

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

April 29, 1988

In Brief: Schmidt Has Doubts About Community Saturation Program; Diane Fink Wins Gerard Lambert Award

July 25, 1975